Holdings (36)
| Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | Equity | 8.51% |
| Max Healthcare Institute Ltd | Healthcare | Equity | 5.68% |
| Healthcare Global Enterprises Ltd | Healthcare | Equity | 5.52% |
| Divi's Laboratories Ltd | Healthcare | Equity | 5.12% |
| Abbott India Ltd | Healthcare | Equity | 4.97% |
| Cipla Ltd | Healthcare | Equity | 4.77% |
| Apollo Hospitals Enterprise Ltd | Healthcare | Equity | 4.61% |
| Rainbow Childrens Medicare Ltd | Healthcare | Equity | 4.42% |
| Dr. Reddy's Laboratories Ltd | Healthcare | Equity | 4.26% |
| Glaxosmithkline Pharmaceuticals Ltd | Healthcare | Equity | 4.12% |
Returns and rankings
| 1Y | 3Y | 5Y | All | |
|---|---|---|---|---|
| Fund Returns | 9.52% | 21.15% | 15.39% | 9.22% |
| Category Average | -2.14% | 22.11% | 14.61% | NA% |
| Rank Within Category | 17.00% | 7.00% | 5.00% | NA% |
Expense ratio, exit load and tax
Expense ratio: 0.97%
Inclusive of GST
Exit load
Exit load of 0.25% if redeemed within 30 days.
Stamp duty
0.005% (from July 1st, 2020)
Tax implication
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.
Fund management
Education
Mr. Srivastava has done BBA (Banking & Insurance), PGDM - IMT Ghaziabad
Experience
Prior to joining Tata Mutual Fund, he has worked with Incred Asset Management, Kotak Investment Banking, Emkay Global, Evalueserve and Motilal Oswal Financial Services